Fibrinolysis in cardiac arrest.
Cardiac arrest is a classic contraindication for fibrinolysis, due to possible hemorrhagic complications. Most cardiac arrests, particularly those occurring out-of-hospital, are caused by vascular thrombosis, including myocardial infarction and pulmonary embolism, in which fibrinolysis has proved to be an effective treatment. Indeed, there are several reports and clinical trials suggesting that fibrinolysis may be a safe and effective therapeutic option in patients with cardiac arrest of presumed cardiovascular cause. Based on a case of successful fibrinolytic treatment of a pulmonary embolism patient with cardiac arrest, these questions are reviewed.
Baptista
Sérgio Bravo
SB
Serviço de Cardiologia, Hospital Fernando Fonseca Amadora, Portugal.
Ferreira
Daniel
D
Ferreira
Rafael
R
D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006323:Heart Arrest / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D011655:Pulmonary Embolism / Q000150:complications / Q000188:drug therapy; D015912:Thrombolytic Therapy; D014463:Ultrasonography
D005343:Fibrinolytic Agents